Alnylam Pharmaceuticals
ALNY
#642
Rank
โ‚ฌ30.11 B
Marketcap
229,84ย โ‚ฌ
Share price
-0.77%
Change (1 day)
66.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company